Trial intelligence / Profile preview

Heart Function in RA and AS Patients on TNF Blockers

NCT01072058Phase 4Unknown

Sponsor
Universidade de São Paulo
Start
Feb 2008
Primary completion
Feb 2011
Modality
Monoclonal Antibodies, Fc-Fusion Proteins
Countries
1
01

Overview

A Phase 4 trial of infliximab, adalimumab, etanercept in rheumatoid arthritis (RA), ankylosing spondylitis (AS), sponsored by Universidade de São Paulo. Status: unknown.

02

Drugs

infliximabadalimumabetanercept
03

Conditions

rheumatoid arthritis (RA)ankylosing spondylitis (AS)

Beyond the preview

Go deeper on NCT01072058.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01072058.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call